Goldman Sachs Group Inc Dyne Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 670,484 shares of DYN stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
670,484
Previous 2,095,749 68.01%
Holding current value
$16.1 Million
Previous $74 Million 67.44%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$31.94 - $47.04 $45.5 Million - $67 Million
-1,425,265 Reduced 68.01%
670,484 $24.1 Million
Q2 2024

Aug 13, 2024
BUY
$23.65 - $35.63 $10.3 Million - $15.5 Million
434,661 Added 26.17%
2,095,749 $74 Million
Q1 2024

May 15, 2024
BUY
$13.06 - $29.18 $6.53 Million - $14.6 Million
500,316 Added 43.1%
1,661,088 $47.2 Million
Q4 2023

Feb 13, 2024
SELL
$6.62 - $13.64 $2.3 Million - $4.74 Million
-347,370 Reduced 23.03%
1,160,772 $15.4 Million
Q3 2023

May 14, 2024
BUY
$8.6 - $12.18 $2.99 Million - $4.23 Million
347,370 Added 29.93%
1,508,142 $13.5 Million
Q3 2023

Nov 14, 2023
SELL
$8.6 - $12.18 $4.31 Million - $6.11 Million
-501,387 Reduced 24.95%
1,508,142 $13.5 Million
Q2 2023

May 14, 2024
BUY
$8.53 - $14.28 $4.39 Million - $7.36 Million
515,079 Added 34.47%
2,009,529 $22.6 Million
Q2 2023

Aug 14, 2023
BUY
$8.53 - $14.28 $4.39 Million - $7.36 Million
515,079 Added 34.47%
2,009,529 $22.6 Million
Q1 2023

May 14, 2024
BUY
$10.88 - $15.0 $7.16 Million - $9.88 Million
658,433 Added 78.76%
1,494,450 $17.2 Million
Q1 2023

May 11, 2023
BUY
$10.88 - $15.0 $7.16 Million - $9.88 Million
658,433 Added 78.76%
1,494,450 $17.2 Million
Q4 2022

May 14, 2024
BUY
$9.37 - $13.8 $4.11 Million - $6.05 Million
438,447 Added 110.28%
836,017 $9.69 Million
Q4 2022

Feb 13, 2023
BUY
$9.37 - $13.8 $4.11 Million - $6.05 Million
438,447 Added 110.28%
836,017 $9.69 Million
Q3 2022

May 14, 2024
BUY
$7.2 - $15.17 $2.39 Million - $5.03 Million
331,527 Added 501.99%
397,570 $5.05 Million
Q3 2022

Nov 10, 2022
BUY
$7.2 - $15.17 $2.39 Million - $5.03 Million
331,527 Added 501.99%
397,570 $5.05 Million
Q2 2022

May 14, 2024
SELL
$4.36 - $10.5 $4.77 Million - $11.5 Million
-1,094,729 Reduced 94.31%
66,043 $454,000
Q2 2022

Aug 15, 2022
SELL
$4.36 - $10.5 $54,561 - $131,397
-12,514 Reduced 15.93%
66,043 $454,000
Q1 2022

May 16, 2022
SELL
$6.52 - $12.27 $39,517 - $74,368
-6,061 Reduced 7.16%
78,557 $757,000
Q4 2021

Feb 14, 2022
BUY
$11.89 - $16.07 $539,199 - $728,758
45,349 Added 115.48%
84,618 $1.01 Million
Q3 2021

Nov 10, 2021
BUY
$15.6 - $21.46 $612,596 - $842,712
39,269 New
39,269 $637,000

Others Institutions Holding DYN

# of Institutions
209
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email